Patients and Partnerships Archives -

Deep Dive/ Patients/ Views & Analysis/ Views and analysis

How the combination treatment challenge impacts patients and how we are working together to solve it

mike.hammerton@pharmaphorum.com Deep Dive, Deep Dive: Patients and Partnerships, Eric Low, Helen Taylor, patients, Patients and Partnerships, Takeda 0 Comment

How the combination treatment challenge impacts patients Access to medicines attracts a great deal of interest from patients,

How the combination treatment challenge impacts patients and how we are working together to solve it

https://pharmaphorum.com/patients/takeda-combination-challenge-impacts-patients/

Deep Dive/ Patients/ Views & Analysis/ Views and analysis

Recruiting patients to increase diversity & inclusion in clinical trials: one size does not fit all

mike.hammerton@pharmaphorum.com Deep Dive, Deep Dive: Patients and Partnerships, ICON, Patients and Partnerships, Seth Nelson 0 Comment

More so now than ever, the inclusion of more diverse, and often more relevant, study populations is gathering

Recruiting patients to increase diversity & inclusion in clinical trials: one size does not fit all

https://pharmaphorum.com/deep-dive/recruiting-patients-increase-diversity-inclusion-clinical-trials/

Deep Dive/ Patients/ Views & Analysis/ Views and analysis

The booming life sciences sector needs dynamic real estate support

mike.hammerton@pharmaphorum.com bruntwood SciTech, Deep Dive, Deep Dive: Patients and Partnerships, Dr Kath Mackay, Life Sciences, Patients and Partnerships 0 Comment

Bruntwood SciTech is the UK’s leading property provider dedicated to driving the growth of the science and technology

The booming life sciences sector needs dynamic real estate support

https://pharmaphorum.com/patients/bruntwood-scitech-life-sciences-real-estate-support/

Deep Dive/ Patients/ Views & Analysis/ Views and analysis

How biomarkers and bioanalytics are changing R&D

mike.hammerton@pharmaphorum.com Deep Dive, Deep Dive: Patients and Partnerships, Nexelis, Patients and Partnerships, Thomas Turi 0 Comment

Biomarkers have been causing a paradigm shift in how HCPs treat patients for some time – now they

How biomarkers and bioanalytics are changing R&D

https://pharmaphorum.com/patients/how-biomarkers-and-bioanalytics-are-changing-rd/

Deep Dive/ Patients/ Views & Analysis/ Views and analysis

Health literacy for the intellectually disabled: is pharma doing enough?

mike.hammerton@pharmaphorum.com Deep Dive, Deep Dive: Patients and Partnerships, health literacy, Olivia Kersey, Patients and Partnerships, Prime Global 0 Comment

What is health literacy and why is it important? Health literacy (HL), defined by the CDC as the

Health literacy for the intellectually disabled: is pharma doing enough?

https://pharmaphorum.com/patients/prime-global-health-literacy-intellectually-disabled-pharma/

Deep Dive/ Patients/ Views & Analysis/ Views and analysis

Leveraging real-world data to meet payers’ needs

mike.hammerton@pharmaphorum.com Certara, Deep Dive, Deep Dive: Patients and Partnerships, Lee Stern, Patients and Partnerships, real world data, Shawn Bates 0 Comment

Payers are becoming savvier in accepting real-world data. Certara’s Lee Stern and Shawn Bates discuss the challenges and

Leveraging real-world data to meet payers’ needs

https://pharmaphorum.com/patients/leveraging-real-world-data-meet-payers-needs/

Deep Dive/ Patients/ Views & Analysis/ Views and analysis

Time for a new model in patient access

mike.hammerton@pharmaphorum.com Astellas, Astellas Pharma Europe, Deep Dive, Deep Dive: Patients and Partnerships, Mig Sleeper, Patients and Partnerships 0 Comment

Mig Sleeper, vice president, Global Pricing for Astellas Pharma Europe, explains why we must rethink how value is

Time for a new model in patient access

https://pharmaphorum.com/patients/time-for-a-new-model-in-patient-access/

Deep Dive/ Patients/ Views & Analysis/ Views and analysis

Time to take patient engagement to the next level

mike.hammerton@pharmaphorum.com Dawn Lobban, Deep Dive, Deep Dive: Patients and Partnerships, Envision Pharma, Patients and Partnerships, Sarah Avent 0 Comment

Patient engagement in pharma is evolving, with some companies doing it better than others. Envision Pharma Group’s Dawn

Time to take patient engagement to the next level

https://pharmaphorum.com/patients/envision-pharma-patient-engagement-next-level/

Deep Dive/ Patients/ Views & Analysis/ Views and analysis

Patients want to be heard. Is pharma listening?

mike.hammerton@pharmaphorum.com Axon, Deep Dive, Deep Dive: Patients and Partnerships, Natalie Turner, Patients and Partnerships 0 Comment

A common theme heard from the advocacy groups AXON works with is “Nothing for us without us,” says

Patients want to be heard. Is pharma listening?

https://pharmaphorum.com/patients/patients-want-to-be-heard-pharma-axon/

Trending

Patients and Partnerships

Login